Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer

N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), C. Kannengiesser (Paris, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de la Réunion, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), V. Cottin (Lyon, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Lyon, France), P. De Vuyst (Brussels, Belgium), P. Duquesnoy (Paris, France), V. Giraud (Boulogne Billancourt, France), C. Gomez (Marseille Billancourt, France), L. Gouya (Colombes Billancourt, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), J. Traclet (Lyon, France), A. Coulomb L'Hermine (Paris, France), A. Clement (Paris, France), S. Amselem (Paris, France)

Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), C. Kannengiesser (Paris, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de la Réunion, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), V. Cottin (Lyon, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Lyon, France), P. De Vuyst (Brussels, Belgium), P. Duquesnoy (Paris, France), V. Giraud (Boulogne Billancourt, France), C. Gomez (Marseille Billancourt, France), L. Gouya (Colombes Billancourt, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), J. Traclet (Lyon, France), A. Coulomb L'Hermine (Paris, France), A. Clement (Paris, France), S. Amselem (Paris, France). Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer. 2235

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer
Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020
Year: 2020



SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017

Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer
Source: International Congress 2016 – IPF pathogenesis
Year: 2016


Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP)
Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Year: 2018



Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017




Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias
Source: Eur Respir J 2007; 29: 134-137
Year: 2007



Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021



Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011



Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients.
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018



Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Lung cancer is frequently developed in patients with idiopathic interstitial pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 579s
Year: 2007

Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018



Classification of different ABCA3 mutations causing interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3G964A
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Lung cancer as a comorbidity in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012

Polymorphism of the genes of xenobiothics detoxification in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004

Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


Two new NKX2-1 mutations associated with pediatric interstitial lung diseases
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Mitochondrial tRNA gene mutations in patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016